DEERFIELD BEACH, Fla.--(BUSINESS WIRE)--Researchers at University of Texas, Galveston, in collaboration with Cell Science Systems, Corp., recently reported in the British Journal of Gastroenterology, results of a one-year weight loss study.
The study, entitled, Food Allergen Elimination for Obesity Reduction; a Longitudinal, Case-Control Trial, was designed to examine the weight loss and body composition effects of following a food sensitivity avoidance diet either alone or in conjunction with exercise. Study participants had to have a minimum BMI (body mass index) of 30 to participate in the study. For reference, a BMI of 30 in a 5’ 3” female would be 170 lbs.
Food sensitivities were determined using the ALCAT Test, performed at Cell Science Systems’ laboratory in Deerfield Beach, FL. The ALCAT Test had previously demonstrated benefit in achieving short term improvement in scale weight and/or body composition in 98% of subjects in a 100-person controlled trial carried out at Baylor Medical College.
The UT researchers wanted to see if the benefits of food elimination determined by the ALCAT Test were durable, and reduced waist size, which is a major indicator of risk for diabetes, heart disease and immune dysregulation associated with COVID-19. The study did show significant long-term benefits in weight loss and decrease in waist size as well as BMI.
Study subjects were divided into four groups: Group 1, the ALCAT Test alone (23 subjects). Group 2, the ALCAT Test together with aerobic surge exercise (also 23 subjects) or, Group 3, exercise only (18 subjects) and a 4th group, that did neither exercise nor food elimination, served as controls.
Those following both the ALCAT Test food recommendations together with the exercise regimen shed, on average, 32.2 lbs., 4.3 inches in waist size, and had a 4.6 score reduction in BMI. Those following the ALCAT Test alone experienced nearly the same benefit; also losing pounds, waist dimension and reduction BMI. All groups fared significantly better than the control group that implemented neither modality. Study link: https://britishjournalofgastroenterology.com/volume-2-issue-4.
This further confirms what several other studies have reported: consumption of foods that elicit an immune response, according to the ALCAT Test, interferes with the ability to lose weight; more importantly, to lose fat, even when exercising. If this seems illogical considering the maxim: calories in vs. calories out, determines weight it’s because inflammation inhibits proper metabolism. Too much body inflammation can mean calories are stored as fat instead of being burnt for energy.
The ALCAT Test determines how the relevant immune cells respond to foods and other substances. It is more effective in reducing the body burden of inflammation than other approaches using antibody tests or DNA analysis. Antibody tests show an exposure, not an actual sensitivity. Therefore, labs use the very same type of testing to determine if a person has been exposed to COVID-19 even if they are not currently infected. Hence, IgG and IgA antibody tests tell if a person has been exposed to the food in question but not if there is an actual sensitivity.
DNA analysis suggests possibilities - not actualities. This is because there are many genes involved in immune and metabolic responses; and any given gene may or may not even be expressed. Thus, even identical twins can react to the same food in vastly different ways.
As a major driver of diabetes, heart disease, some cancers, and now COVID-19 outcomes, achieving and maintaining a healthy weight is more important than ever. Americans spend over $70 billion annually on diets and other weight loss products and services. The indirect costs of obesity to the healthcare system also number in the hundreds of billions. The ALCAT Test can substantially reduce this burden and may now become the new gold standard for guiding personalization of therapeutic dieting aimed at achieving healthy weight for those who want to invest in their most valuable asset- their health.
About Cell Science Systems, Corp. (CSS) www.CellScienceSystems.com
Cell Science Systems, a CLIA licensed lab and FDA registered medical device manufacturer, is the developer and sole provider of the ALCAT Test®. CSS also provides several tests aimed at nutritional assessment, gut health, metabolic function and prevention. Through its wholly owned subsidiary in Potsdam, Germany, CSS services Europe and Middle East. In partnership with PreviMedica Group, LLC, CSS also provides customized health programs to organizations.
